Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-5c6d5d7d68-7tdvq Total loading time: 0 Render date: 2024-08-06T22:32:09.310Z Has data issue: false hasContentIssue false

Chapter 20 - Mature B-Cell Non-Hodgkin Neoplasms

from Section V - Mature Lymphoid Neoplasms

Published online by Cambridge University Press:  25 January 2024

By
Xiayuan Liang
Edited by
Xiayuan Liang ,
Bradford Siegele  and
Jennifer Picarsic
Xiayuan Liang
Affiliation:
Children’s Hospital of Colorado
Bradford Siegele
Affiliation:
Children’s Hospital of Colorado
Jennifer Picarsic
Affiliation:
Cincinnati Childrens Hospital Medicine Center
Get access

Summary

Non-Hodgkin lymphomas (NHLs) of childhood and adulthood differ considerably in biology, incidence, treatment, and outcome [1]. Pediatric NHLs are nearly evenly split between B-cell and T-cell neoplasms, whereas in adults, nearly 80% of NHLs are of B-cell origin [2]. The vast majority of mature B-cell NHLs in children and adolescents are high-grade, including Burkitt lymphoma/leukemia (BL), diffuse large B-cell lymphoma (DLBCL), and other less common histologies. Extranodal disease is more common in children than in adults [2]. Pediatric-type follicular lymphoma and nodal and extranodal marginal-zone lymphoma are uncommon in the pediatric population, accounting for <10% of mature B-cell lymphomas among patients <18 years of age [1]. The current classification of mature B-cell lymphoma is reviewed comprehensively in the 2017 WHO Classification published by the World Health Organization (WHO). Some of these entities occur only in adults. The entities that can occur in pediatric patients are discussed in the following sections [2].

Type
Chapter
Information
Pediatric Pathology of Hematopoietic and Histiocytic Disorders , pp. 235 - 262
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Woessmann, W, Quintanilla‐Martinez, L. Rare mature B‐cell lymphomas in children and adolescents. Hematological Oncology. 2019;37:53–61.Google Scholar
Perkins, SL. Pediatric mature B-cell non-Hodgkin lymphomas. In: Proytcheva, MA, ed. Diagnostic pediatric hematopathology. Cambridge, UK: Cambridge University Press; 2011:395–428.Google Scholar
Leoncini, L, Campo, E, Stein, H, et al. Burkitt lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:330–4.Google Scholar
Gascoyne, RD, Siebert, R, Connors, JM, et al. Burkitt’s lymphoma, and its mimics. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:447–64.Google Scholar
Dunleavy, K, Little, RF, Wilson, WH. Update on Burkitt lymphoma. Hematol Oncol Clin North Am. 2016;30:1333–43.Google Scholar
Ambrosio, MR, Navari, M, Di Lisio, L, et al. The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma. Infectious Agent Cancer. 2014;9:1–2.Google Scholar
Fish, K, Chen, J, Longnecker, R. Epstein-Barr virus latent membrane protein 2 A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma. Blood. 2014;123:530–40.Google Scholar
Navid, F, Mosijczuk, AD, Head, DR, et al. Acute lymphoblastic leukemia with the (8;14)(q24; q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. Leukemia. 1999;13:135–41.Google Scholar
Gascoyne, R.D., Campo, E, Jaffe, ES, et al. Diffuse large B-cell Lymphoma, NOS. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France:IARC Press;2017:291–7.,Google Scholar
Chan, ACL, Chan, JKC. Diffuse large B-cell lymphoma. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:415–45.Google Scholar
Li, S, Young, KH, Medeiros, LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50:74–87.Google Scholar
Hu, S, Xu-Monette, ZY, Balasubramanyam, A, et al. CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Blood. 2013;121:2715–24.Google Scholar
Gaulard, P, Harris, NL, Pileri, SA, et al. Primary mediastinal (thymic) large B-cell lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissues. Rev. 4th ed. Lyon, France: IARC Press; 2017:314–6.Google Scholar
Martelli, M, Ferreri, A, Di Rocco, A, et al. Primary mediastinal large B-cell lymphoma. Crit Rev Oncol Hematol. 2017;113:318–27.Google Scholar
Oschlies, I, Burkhardt, B, Salaverria, I, et al. Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children. Haematologica. 2011;96:262–8.Google Scholar
Ott, G, Delabie, J, Gascoyne, RD, et al. T-cell/histiocyte-rich large B-cell lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France:IARC Press; 2017:298–9.Google Scholar
Pittaluga, S, Jaffe, ES. T-cell/histiocyte-rich large B-cell lymphoma. Haematologica. 2010;95:352–6.Google Scholar
Nam-Cha, SH, Roncador, G, Sanchez-Verde, L, et al. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J Surg Pathol. 2008;32:1252–7.Google Scholar
Hartmann, S, Döring, C, Vucic, E, et al. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma. Br J Haematol. 2015;169:415–22.CrossRefGoogle ScholarPubMed
Jaffe, ES, Harris, NL, Swerdlow, SH, et al. Follicular lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al.. eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:266–73.Google Scholar
Jaffe, ES, Harris, NL, Siebert, R. Pediatric-type follicular lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:278–9.Google Scholar
Ferry, JA, de Level, L, Louissaint, A Jr., et al. Follicular lymphoma. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:321–52.Google Scholar
Attarbaschi, A, Abla, O, Arias Padilla, L, et al. Rare non‐Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric‐type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T‐cell lymphoma. Pediatr Blood Cancer. 2020;67:e28416.Google Scholar
Liu, Q, Salaverria, I, Pittaluga, S, et al. Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol. 2013;37:333–43.Google Scholar
Pittaluga, S, Harris, NL, Siebert, R, et al. Large B-cell lymphoma with IRF4 rearrangement. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:280–1.Google Scholar
Sukswai, N, Lyapichev, K, Khoury, JD, et al. Diffuse large B-cell lymphoma variants: an update. Pathology. 2020;52:53–67.Google Scholar
Campo, E, Pileri, SA, Jaffe, ES, et al. Nodal marginal zone lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:263–5.Google Scholar
Jaffe, ES. Nodal marginal zone lymphoma. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:383–96.Google Scholar
Attygalle, AD, Liu, H, Shirali, S, et al. Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction. Blood. 2004;104:3343–8.Google Scholar
Kluin, PM, Harris, NL, Stein, H, et al. High-grade B-cell lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:335–41.Google Scholar
Sesques, P, Johnson, NA. Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements. Blood. 2017;129:280–8.Google Scholar
Kluin, PM, Harris, NL, Stein, H, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. 4th ed. Lyon, France: IARC Press; 2008:265–6.Google Scholar
Jaffe, ES, Stein, H, Swerdlow, SH, et al. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classic Hodgkin lymphoma. In: Swerdlow, SH, Campo, E, Harris, NL, et al. eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed. Lyon, France: IARC Press; 2017:342–4.Google Scholar
Fend, F. Classical Hodgkin’s lymphoma and related lesions. In: Jaffe, ES, Arber, DA, Campo, E, et al., eds. Hematopathology. 2nd ed. Philadelphia, PA: Elsevier; 2017:525–45.Google Scholar
Sarkozy, C, Copie-Bergman, C, Damotte, D, et al. Gray-zone lymphoma between CHL and large B-cell lymphoma. Am J Surg Pathol. 2019;43:341–51.Google Scholar
Leoncini, L, Campo, E, Stein, H, et al. Burkitt-like lymphoma with 11q aberration. In: Swerdlow, SH, Campo, E, Harris, NL, et al., eds. WHO classification of tumours of haematopoietic and lymphoid tissue. Rev. 4th ed.Lyon, France:IARC Press; 2017:334.Google Scholar
Salaverria, I, Martin-Guerrero, I, Wagener, R, et al. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. Blood. 2014;123:1187–98.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×